Which statement about neuraxial anesthesia in HIV-infected parturients is true?

Which statement about neuraxial anesthesia in HIV-infected parturients is true?

• A. Central neuraxial blockade increases neurologic complications
• B. Epidural blood patch is contraindicated
• C. Epidural or spinal anesthesia is safe for HIV-infected parturients
• D. Transmission to the newborn occurs in 90% if mother is untreated

Answer: (C)

The key idea is that HIV infection by itself does not make neuraxial anesthesia unsafe. Spinal or epidural techniques can be used safely in HIV-infected parturients as long as there are no other contraindications, such as significant coagulopathy or active infection at the puncture site. HIV does not inherently raise the risk of neurologic injury from central neuraxial blockade, nor does it affect the mechanism of neuraxial analgesia during labor when the patient’s blood counts and coagulation are normal. The statement about epidural blood patches being contraindicated due to HIV isn’t supported, since the patch uses the patient’s own blood and is primarily limited by standard infection precautions. The idea that neuraxial anesthesia would dramatically increase neurologic complications in HIV patients isn’t supported, and vertical transmission to the newborn is not determined by neuraxial anesthesia; with effective antiretroviral therapy the transmission risk is much lower than 90%. So the best approach is that epidural or spinal anesthesia is safe for HIV-infected parturients when evaluated for coagulation status and infection risk, and used with standard sterile technique.

The key idea is that HIV infection by itself does not make neuraxial anesthesia unsafe. Spinal or epidural techniques can be used safely in HIV-infected parturients as long as there are no other contraindications, such as significant coagulopathy or active infection at the puncture site. HIV does not inherently raise the risk of neurologic injury from central neuraxial blockade, nor does it affect the mechanism of neuraxial analgesia during labor when the patient’s blood counts and coagulation are normal.

The statement about epidural blood patches being contraindicated due to HIV isn’t supported, since the patch uses the patient’s own blood and is primarily limited by standard infection precautions. The idea that neuraxial anesthesia would dramatically increase neurologic complications in HIV patients isn’t supported, and vertical transmission to the newborn is not determined by neuraxial anesthesia; with effective antiretroviral therapy the transmission risk is much lower than 90%.

So the best approach is that epidural or spinal anesthesia is safe for HIV-infected parturients when evaluated for coagulation status and infection risk, and used with standard sterile technique.